Back to Search
Start Over
NRx Pharmaceuticals begins enrollment in Phase 2 bipolar depression study
- Source :
- The Fly. May 12, 2022
- Publication Year :
- 2022
-
Abstract
- NRx Pharmaceuticals announced that the first patient has been enrolled in one of the two psychiatry studies that it plans to initiate this year: this first trial is studying patients [...]
- Subjects :
- Bipolar disorder -- Drug therapy
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.703407075